Navigation Links
New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology
Date:12/2/2009

SEATTLE, Dec. 2 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London, the lead investigator for the PIX 301 EXTEND trial will present new data on the pixantrone phase III trial in relapsed/refractory aggressive non-Hodgkin's lymphoma (NHL) at the 51st Annual Meeting of the American Society of Hematology on Saturday, December 5, 2009 in New Orleans, Louisiana.

The presentation is scheduled for Saturday, December 5, 2009 during the "Lymphoma: Chemotherapy, excluding Pre-Clinical Models" session that will be held from 5:30 p.m-7:30 p.m. Central Time. The presentation, abstract #1677, is titled, "Phase III trial of pixantrone dimaleate compared with other agents as third-line, single-agent treatment of relapsed aggressive non-Hodgkin's lymphoma (EXTEND): Results from the treatment and follow-up periods." The abstract is available at www.hematology.org.

Separately, CTI will host an investor and analyst meeting providing an overview of the clinical trial results and potential for pixantrone in relapsed/refractory aggressive NHL on December 5, 2009 in New Orleans, Louisiana. Speakers at the event will include John P. Leonard, M.D., Richard T. Silver, Distinguished Professor of Hematology and Medical Oncology, Weill Cornell Medical College, New York Presbyterian Hospital, and Stanley M. Marks, M.D., Director of Clinical Services and Chief Medical Officer, University of Pittsburgh Medical Center Cancer Centers/University of Pittsburgh Cancer Institute, and James A. Bianco, M.D., CEO of CTI. The presentations will begin at 12:45 p.m. Central /10:45 a.m. Pacific /7:45 p.m. Central European Time and conclude at approximately 2:00 p.m. Central/ 12:00 p.m. Pacific/9:30 p.m. Central European Time. The presentations will be webcast live with slides. Webcast and conference call details are as follows:

Saturday, Dec
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cell Therapeutics Initiating Rolling NDA Submission for Pixantrone
2. Pixantrone Now Available in Europe on a Named-Patient Basis
3. Cell Therapeutics Reports 76% Decrease in First Quarter 2009 Net Loss Attributable to Common Shareholders; Completion of Pixantrone NDA Submission on Track for Second Quarter 2009
4. Pixantrone Overview in Non-Hodgkins Lymphoma to be Presented at 2009 Pan Pacific Lymphoma Conference
5. Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review
6. Cell Therapeutics Initiates Process to Obtain Marketing Approval for Pixantrone in Europe
7. FDA Accepts to File Cell Therapeutics New Drug Application for Pixantrone
8. Ovation further advances development pipeline with new phase III epilepsy study
9. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
10. Mannatech Launches Phase One of New Sales and Training Tools
11. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... of the leading online stores of real and synthetic hair ... human hair lace wigs inspired by 6 famous celebrities. It’s ... latest celebrity hairstyles are. , For people who ... to choose from: a style of yaki straight lace wig, ... ombre red lace wig. People can go to the product ...
(Date:9/21/2014)... United-Kingdom (PRWEB) September 22, 2014 PhUSE ... Sweeney and Dr. Lilliam Rosario as keynote speakers for ... Following keynotes from Dr. Ben Goldacre in 2013 ... Professor Lord Winston in 2011 , PhUSE again presents ... who are passionate about advancement of clinical information. , ...
(Date:9/21/2014)... September 21, 2014 Waldorf Risk ... Management Portal designed for Diocesan risks. The portal ... to support effective risk management and loss control ... live coinciding with Waldorf’s exhibition at the Diocesan ... These applications were developed in collaboration with three ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 The ... BHWG) will host a statewide symposium ( tinyurl.com/ILBHC14 ... Veterans, and their Families. Sponsored by the VNA ... Lottery Cash Grant, and Health & Disability Advocates, ... at the Hilton Hotel in Springfield, IL. ...
(Date:9/21/2014)... Cheap Hosting USA, one of the leading review websites, ... the best Reseller hosting suppliers in 2014. “It is ... these companies have outperformed their competitors on hosting features, ... the best web hosting at affordable rates,” the site’s ... reseller hosting is a very popular way for webmasters ...
Breaking Medicine News(10 mins):Health News:UniWigs New Arrivals Just In- Human Hair Lace Wigs Inspired By Famous Celebrities 2Health News:PhUSE announces Final List of Industry Influencers as Keynote Speakers 2Health News:PhUSE announces Final List of Industry Influencers as Keynote Speakers 3Health News:Waldorf Risk Solutions Releases New Risk Management Portal 2Health News:Enhancing Clinical Competence to Serve Veterans, a Statewide Symposium 2Health News:Enhancing Clinical Competence to Serve Veterans, a Statewide Symposium 3Health News:Best Cheap Hosting USA Announces The Best Reseller Hosting Suppliers In 2014 2
... at the University of Cincinnati (UC) suggests that ... process that can provide cells with nutrients from ... can protect tumor cells from chemotherapy, allowing them ... a hidden, dormant, metastatic state. In this ...
... NY It should be possible to significantly improve ... drugs, say scientists at Cold Spring Harbor Laboratory (CSHL), ... cells with their immediate surroundings, called the tumor microenvironment. ... Cancer Cell , CSHL Assistant Professor Mikala Egeblad ...
... , MONDAY, April 16 (HealthDay News) -- The ... surgery increased drastically in 2011, according to the American ... augmentation procedures was greater than breast augmentation, Botox injections ... chin augmentation may include increased use of video-chat technology, ...
... Indiana University and the Regenstrief Institute have developed an ... the specific health needs of each patient in the ... new study, "Automated Primary Care Screening in Pediatric Waiting ... found that by personalizing and automating the patient ...
... the place where an estimated 30 percent of Americans die, there ... job at managing end of life care. A new study ... is starting a discussion over the need to create end of ... nursing homes with incentive to improve care. "Nursing homes are ...
... (April 16, 2012) Cancer is much more likely in the ... to fight the disease and the often-toxic side effects of treatment. ... Research Center at The University of Texas Health Science Center at ... work only in younger patients can be used to help the ...
Cached Medicine News:Health News:Specific inhibition of autophagy may represent a new concept for treatment of kidney cancer 2Health News:Live imaging shows response to cancer drugs can be boosted by altering tumor microenvironment 2Health News:Live imaging shows response to cancer drugs can be boosted by altering tumor microenvironment 3Health News:Chin Implant Surgeries On the Rise in U.S. 2Health News:IU, Regenstrief automated system aims to improve child health 2Health News:IU, Regenstrief automated system aims to improve child health 3Health News:Study recommends ways to evaluate end-of-life care in nursing homes 2Health News:Study recommends ways to evaluate end-of-life care in nursing homes 3Health News:Immunotherapy for elderly cancer patients finds new promise in drug combination 2Health News:Immunotherapy for elderly cancer patients finds new promise in drug combination 3
(Date:9/19/2014)... -- The American Association for Homecare (AAHomecare) is pleased ... joined the AAHomecare Corporate Partner Program. ... been actively involved in AAHomecare for much of the ... into a major global manufacturer of home medical equipment. ... increase efforts on behalf of the HME sector in ...
(Date:9/19/2014)... Sept. 19, 2014 UBM Medica US announces ... online community to help oncologists and other clinicians gain ... the use of targeted therapies and immunotherapies, discusses some ... treatment.  Every September, Blood Cancer ... raise awareness about blood cancers—helping to increase survival rates ...
(Date:9/19/2014)... Larry J. Merlo , President and CEO of CVS ... National Press Club in Washington, D.C. ... selling tobacco products and its leadership in driving the innovations ... changes in our health care system pose enormous challenges to ... "CVS Health has a truly unique combination of business assets ...
Breaking Medicine Technology:Drive Medical Design & Manufacturing Joins AAHomecare Corporate Partner Program 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3
The GC OIA test is a rapid assay for the diagnosis of gonorrhea. Thermo solved the challenge of developing a specific rapid assay for Neisseria gonorrhea by using the proprietary ribosomal protein, ...
... is a high performance assay for the ... B with a simple, easy-to-use test that ... minutes. Assay advantages include superior performance with ... to 14-day viral culture enables you to ...
... The CHLAYMDIA OIA test delivers 100% ... results in 19 minutes. With ... not returning for follow-up, this assay ... which can contribute to detection and ...
... therapy and nerve block procedures, Cadwells ... has a precisely machined Trocar (beveled) ... attached 61-cm (24-in) lead wire. Needle ... patient use only. A starter kit ...
Medicine Products: